Effect of PCI on quality of life in patients with stable coronary disease.
William S Weintraub, John A Spertus, Paul Kolm...
https://pubmed.ncbi.nlm.nih.gov/18703470/Actively Recruiting
Led by Kırıkkale University · Updated on 2026-03-03
100
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating erectile function changes in male patients who undergo percutaneous coronary intervention PCI for either a heart attack or stable angina. The study aims to understand how myocardial infarction affects erectile function over time and to explore whether erectile dysfunction can predict future cardiac events. This observational study compares erectile function between patients with myocardial infarction and those with stable angina using standardized questionnaires. Participants are grouped into two sets those treated with PCI after a heart attack and those treated due to stable angina. Erectile function is assessed at baseline after recovery from PCI, and at 3 and 6 months post-procedure using the International Index of Erectile Function IIEF questionnaire. Additional assessments include the Beck Depression Inventory and Fear of Cardiac Recurrence and Progression Scale. Researchers also collect clinical data such as cardiac vessel scores, ejection fraction, testosterone levels, body measurements, medication use, and the intervention method. During the study, male participants aged 30 to 75 will complete face-to-face interviews and questionnaires at specified intervals baseline, 3 months, and 6 months after PCI. The study measures changes in erectile function scores over time and examines associations with cardiac health, depression, and anxiety symptoms. Safety and participation are monitored throughout the follow-up period. The total duration of involvement is up to 6 months, with evaluations focusing on erectile function and related health parameters.
CONDITIONS
"Erectile Function After PCI in MI and Non-MI Patients"
T
Timucin Sipal, MD, PhD
C
Caglar Alp, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kırıkkale University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants who have undergone successful percutaneous coronary intervention (PCI) are observed to assess erectile function and related factors over time.
3 visits (baseline, 3 months, and 6 months; face-to-face interviews in clinical environment)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
William S Weintraub, John A Spertus, Paul Kolm...
https://pubmed.ncbi.nlm.nih.gov/18703470/Sarah T Clarke, Michael Le Grande, Barbara M Murphy...
https://pubmed.ncbi.nlm.nih.gov/39027197/Piero Montorsi, Paolo M Ravagnani, Stefano Galli...
https://pubmed.ncbi.nlm.nih.gov/16901623/Gabriela Dostálová, Zuzana Hlubocká, Kristýna Bayerová...
https://pubmed.ncbi.nlm.nih.gov/28697641/L Vacanti, B Caramelli
https://pubmed.ncbi.nlm.nih.gov/15538397/Enisa Hodžić, Adnan Durek, Edin Begić...
https://pubmed.ncbi.nlm.nih.gov/30589239/Ahmed Adam, Jared McDowall, Sunday Joseph Aigbodion...
https://pubmed.ncbi.nlm.nih.gov/33224004/Kırıkkale University
Lead Sponsor